24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Medi-Tate
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:32
Melisron CEO Ophir Sarid dies at 54 after sudden illness
18:15
Noa Argamani joins Vine Ventures to help Israeli startups break into the U.S.
17:39
Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes
16:00
Wix's Base44 launches Base Code to take on Claude Code and Cursor
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle’s co-CEOs got $350 million in equity awards. A year later, the stock had lost half its value
2
Intel has 70 people working on quantum computing. Its CEO is betting on the next frontier
3
Assaf Rappaport: “I received an envelope with $30 billion written on it. I said no right away”
4
Intel CEO says he uses AI agents every day to cut hours of research to minutes
5
IAI and Elbit win $127 million in new U.S. Navy contracts
More news
Medi-Tate
2 stories about Medi-Tate
Israel’s Medi-Tate acquired by Japanese powerhouse Olympus Corporation for $300 million
26.02.21
|
Meir Orbach
The Israeli manufacturer of non-surgical solutions for BPH had previously raised $37 million from private investors
Japan's Olympus Corporation Backs Israeli Medical Company Medi-Tate
05.11.18
|
CTech
Olympus agreed to invest $20 million in Medi-Tate, which develops medical devices to relieve symptoms of benign prostate enlargement